Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
US9527805B2 · kind B2 · utility
1Cited by
2References
7Claims
0Family size
Inventors
Key dates
| Filing date | Sep 12, 2011 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Mar 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/48
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides for novel compounds which are inhibitors of lysine-specific demethylase 1 (LSD1) such as those according to Formula II. Such compounds may be used to treat disorders, including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.